Allucent Expands Use of Medidata Clinical Cloud to Accelerate New Drug Development for Unmet Patient Needs
Medidata, a Dassault Systèmes company, today announced that Allucent, a contract research organization (CRO) bringing innovation to biopharma companies, is expanding the global use of Medidata’s Clinical Cloud to advance its end-to-end clinical trial operations offering.
The agreement expands Allucent’s existing utilization of Medidata technologies. These include Rave EDC, eCOA, RTSM, and Rave Imaging, in support of critical areas of development, including oncology, rare and orphan indications, and cell and gene therapies. As part of this agreement, Allucent’s team also achieved 100% Rave EDC certification, reinforcing their commitment to quality, and providing their clients with best-in-class technology.
"Our partnership with Medidata allows us to continue to bring our customers the level of patient focus and insights they need and expect,” said Emily Moore, president of Biometrics at Allucent. “Making the Medidata Clinical Cloud platform available to our clients was an important step to enabling us to accelerate clinical trial development for our customers – small and mid-sized biotech companies.”
“Allucent is leveraging the power of the Medidata Clinical Cloud to solidify their position at the forefront of clinical technology,” said Janet Butler, head of Global Sales at Medidata. “Their work with novel therapies requires agile, patient-centric solutions. We are proud to build on our eight-year collaboration to advance the digital transformation of life sciences and deliver clinical innovations to help reach their goals.”
Allucent, a sponsor of Medidata NEXT London, will make a presentation on data analytics for early phase oncology trials. This includes how working with Medidata has helped them apply strategies and visualization techniques to extract the full value of information for all stakeholders.
Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.
About Medidata
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 2,100+ customers and partners access the world's most trusted platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: FR0014003TT8, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata.
About Dassault Systèmes
Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production to achieve a more sustainable world for patients, citizens, and consumers. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com.
3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Systèmes, a French “société européenne” (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and/or other countries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230306005778/en/
Contact information
Tom Paolella
Senior Director, Corporate Communications & Affairs
+1-848-203-7596
thomas.paolella@3ds.com
Paul Oestreicher
External Communications Director
+1-917-522-4692
paul.oestreicher@3ds.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pyramid Analytics revolutionizes “Last Mile” analytics with Tabulate and Solve21.3.2023 16:01:00 CET | Press release
Pyramid Analytics (Pyramid), a leading business analytics and decision intelligence provider, announced today that it is showcasing its latest additions to its award-winning Decision Intelligence Platform—Tabulate, a powerful new business modeling module; and Solve, a decision modeling and optimization plug-in for Tabulate—at the Gartner Data & Analytics Summit in Orlando, Florida, and at SAPinsider Vegas 2023 in Las Vegas, Nevada. Launched in October 2022, Tabulate lets business users model business processes with data in a governed, web-based experience while Solve allows business users to easily build and deploy advanced prescriptive and optimization models to guide data-driven decision-making on live data. Solving the last mile of analytics In an independent research survey of data workers commissioned by Pyramid in 2022, over 50 percent of respondents who already use BI tools said they exported their analytical data to Excel 50 percent of the time or more to build business models
CORRECTING and REPLACING Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal Aortic Aneurysm21.3.2023 15:27:00 CET | Press release
Fourth paragraph, first sentence of release should read: Viz AAA uses artificial intelligence to automatically search for the presence of an abdominal aortic aneurysm from computed tomography angiography (CTA) from any scanner in a hospital network (instead of Viz AAA uses artificial intelligence to automatically search for the presence of an abdominal aortic aneurysm from any computed tomography angiography (CTA) scan of the chest from any scanner in a hospital network.). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230321005445/en/ Viz AAA is the first FDA-cleared AI-powered solution for the detection and triage of suspected AAA. (Photo: Business Wire) The updated release reads: VIZ.AI IS FIRST TO RECEIVE FDA 510(K) CLEARANCE FOR AI ALGORITHM FOR ABDOMINAL AORTIC ANEURYSM New artificial intelligence algorithm flags and triages suspected abdominal aortic aneurysms Viz.ai, the leader in AI-powered disease detection and int
Alveo Technologies Announces ISO 13485:2016 Certification21.3.2023 14:45:00 CET | Press release
Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary be.well™ technology platform, today announced its quality management system (QMS) has achieved ISO 13485:2016 certification for the design, development and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease. The globally recognized ISO 13485 standard, published by the International Standards Organization, sets out requirements for establishing and maintaining quality management systems for the medical device industry. Compliance with the ISO 13485 standard is required for companies to market medical devices in many markets, including the European Union, Canada, Japan, and Australia. In addition, the U.S. Food and Drug Administration has announced plans to harmonize its existing medical device QMS requirements with ISO 13485, proposing new regulations that incorporate ISO 13485 as the foundational requirements. “We are thrilled to achieve ISO 13
Wemade Presents ‘ Wateree’s Enhancement Support Event’ to Boost Growth in MIR M21.3.2023 14:00:00 CET | Press release
Wemade's blockbuster MMORPG MIR M: Vanguard and Vagabond (hereinafter "MIR M") is holding the "Wateree’s Enhancement Support" event starting from March 21st, 2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230321005487/en/ ‘Wateree’s Enhancement Support Event’ for MIR M starts on March 21, 2023 (Graphic: Wemade) For two weeks, users can participate in two attendance events called "Wateree's Enhancement Support 7 Days Check-in," and "Wateree's Illusory Mystic Realm Support 7 Days Check-in." Simply by checking in, users can obtain abundant rewards such as "Enhancement Stone," "Reforging Stone," "Oil of Blessing," "Illusory Mystic Realm Entry Ticket," and the EXP buff item, "Growth Draught," and more, depending on the number of attendances in the Check-in events. There are also special items available in the in-game Shop for improving crafting and enhancement mastery. The "Wateree's Crafting Mastery Support" package, which
MIR4 Updates ‘Sabuk Clash’ to Determine the Most Powerful Clan21.3.2023 14:00:00 CET | Press release
Wemade’s blockbuster MMORPG MIR4 updated Sabuk Clash, clan vs. clan Castle Siege, on March 21st. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230321005465/en/ MIR4 Updates ‘Sabuk Clash,’ a tournament style Castle Siege content to determine the Emperor’s Clan, on March 21 (Graphic: Wemade) “Sabuk Clash” is a tournament style Castle Siege content where King’s clans from all servers in each region gather in the Domination Server and fight to become the Emperor’s clan. Only Bicheon Castle King’s clans can participate. The winning clan then becomes the Emperor’s clan, which can collect taxes from the Kings of all servers in each region, adjust individual tax rates per server, and is given authority to manage the Sabuk Castle territory. The first round begins on March 26th at 10 pm, and a new round will be held every week for a total of 3 rounds over 3 weeks. In the first round, a total of 16 clans fight to capture one of the 8